|
THIRD COMMISSION MEETING 6 - 7 DECEMBER 2000 ROYAL HORTICULTURAL HALLS CONFERENCE CENTRE LONDON
MINUTES
Summary
The
meeting on Wednesday 6 December opened with a briefing session for
Commission Members on ethical issues surrounding the Commission's
work. This was followed by the introduction to members of representatives
from Citigate Westminster, who would be working with members on AEBC
communications. The meeting also included a preparatory session for
the next day's public meeting.
Dr
Mo Mowlam, Chair of the Cabinet Committee on Biotechnology, Mavis
McDonald, Permanent Secretary at the Cabinet Office and Jo Durning
from the Office of Science and Technology joined members and secretariat
for dinner and informal discussions on the evening of 6 December.
The
Commission held its first public meeting on the morning of Thursday
7 December. People who attended were invited to comment on the Commission's
draft Work Plan. A note of the meeting including an outline of the
views expressed is attached, together with a list of attendees.
Those
attending the public meeting were invited to stay on to observe the
Commission meeting in the afternoon. Members discussed how the Work
Plan should be revised in the light of responses to the written consultation
and the comments they had heard during the morning at the public meeting.
Present
for meetings on both days
Members
Ms Anna Bradley
Professor Michael Banner
Ms Helen Browning
Dr David Carmichael
Dr Philip Dale
Dr Ed Dart
Dr Matthew Freeman
Mr John Gilliland
Professor Malcolm Grant (Chair)
Professor Robin Grove-White
Dr Rosie Hails
Ms Julie Hill (Deputy Chair)
Ms Judith Hann
Ms Edith Iweajunwa
Dr Derek Langslow
Professor Jeff Maxwell
Dr Sue Mayer
Dr Ben Mepham
Ms Justine Thornton
Apologies
for absence
Dr Roger Turner who was unwell had sent his apologies.
Secretariat
Mrs Judith Harris
Mrs Anne Packer
Ms Mileva Novkovic
Mrs Suzanne Knight
Mr John O'Driscoll
Mr Shabber Ahmed
In
attendance
Ms Jo Durning, Office of Science and Technology (Wednesday and Thursday
morning)
Mrs Pat Sellers, Office of Science and Technology (Thursday only)
Mr Simon Rowley, Office of Science and Technology (Thursday morning
only)
Mr Graham Davis, Department of the Environment, Transport and the
Regions
Mr Renaud Wilson, Ministry of Agriculture, Fisheries and Food
Mr David Williamson, Scottish Executive, Rural Affairs Department
Mrs Liz McCullough, Department of the Environment, Northern Ireland
Mr Barry Dare, National Assembly for Wales (Thursday only)
Ms Kate Cutler, Citigate Communications
Mr Barney Wyld, Citigate Communications (Wednesday only)
Ms Tanya Croft, Citigate Communications (Wednesday only)
Wednesday 6 December
Agenda
item 1 - Introductions
1.
David Williamson (SERAD), Jo Durning (OST), Graham Davis (DETR) and
Renaud Wilson (MAFF) were welcomed to their first meeting of the Commission.
2.
Kate Cutler, Barney Wyld and Tanya Croft from Citigate Communications,
who were attending the meeting for the discussion of the Commission's
communications strategy, were also welcomed.
Agenda
item 2 - Briefing on ethical issues surrounding the Commission's work
by Michael Banner and Ben Mepham: papers AEBC/00/17a & b
3.
Following presentations by Michael Banner and Ben Mepham, Members
discussed how best to handle ethical issues given the two approaches
that had been explained to them. Although there were concerns that
the adoption of Ben Mepham's ethical matrix could be too rigid in
certain cases, it was recognised that this approach might offer a
useful framework for consideration of issues on some topics. While
it was difficult to summarise the matrix effectively in so short a
time, Ben Mepham stressed that it aimed to facilitate, rather than
constrain, discussion, and was now used by several academic and industrial
groups in the EU.
4.
Michael Banner proposed that the Commission should be clear about
the constraints on the kind of thinking it was engaged in at any one
time. For example, a cost/benefit approach had limitations because
it did not allow all relevant factors to be considered, and an 'interests'
approach tended to oversimplify. Dialogue, based on a whole range
of factors including philosophical and/or ethical ones, was generally
capable of providing the best way forward on an issue.
5.
The Commission was grateful for this introduction and agreed that
it would return to discussion of its ethical approach (possibly focusing
on specific issues) in future.
Agenda
item 3 - Communications strategy
6.
Representatives of Citigate Communications, who had been contracted
to handle the Commission's press and publicity to the end of March
2002, gave an introductory presentation.
7.
A communications 'audit' would be conducted. The aim of this was to
inform the Commission's media strategy by taking the views of Members
and others e.g. journalists, civil servants, industry and non-governmental
organisations. The strategy subsequently determined and the activity
that developed from it would affect how the public viewed and interacted
with the Commission.
ACTION:
Citigate
8.
In answer to a question from a member, the secretariat explained that
the total value of the sixteen month contract with Citigate was approximately
£90k.
Agenda
item 4 - Preparation for meeting on 7 December
Papers AEBC/00/18 and AEBC 00/18a summarising responses received
9.
Members discussed the conduct of the next day's meetings, which were
to focus on the Work Plan. Members had already seen and been able
to consider responses to the written consultation. A thematic summary
was included in packs for those attending the public meeting and is
being posted on the Commission's website.
10.
It was agreed that the Commission would be in listening mode during
the morning's public meeting rather than respond to individual comments.
This would allow maximum time for members of the audience to make
points. The afternoon would be a formal Commission meeting to discuss
the points made in the written submissions and during the morning
meeting. Members of the public would be able to observe but would
not be able to comment during this part of the meeting.
AOB
11.
Members discussed whether some future meetings or parts of them should
be held in closed session. It was agreed that there would be a presumption
towards openness for at least part of each meeting but that the Commission
should not be defensive about needing private time to deliberate.
The important point was to be open about the format that had been
decided for each meeting and the reasons for the decision.
Thursday
7 December - Public meeting
1.
The Chairman welcomed everyone to the meeting. This was the first
time AEBC was meeting in public, but it would do so regularly in future.
The implications for agriculture and the environment arising from
biotechnology were immense. There were many aspects to be taken into
account - science, ethics, economics, social interests. AEBC was focusing
on the gaps between scientific assessment and public acceptance and,
in doing so, was determined to be open and transparent, especially
in light of the criticisms made by the BSE inquiry of "a secretive
process".
2.
Established in June, AEBC had held two meetings and prepared a draft
Work Plan which had already been the subject of a written consultation.
Members were very grateful for the time and effort people had taken
in responding.
3.
Today's meeting would be a listening one. Convenors of the Commission's
six working groups would outline the three priority and three developmental
areas the Commission had been considering and take comments from the
floor. In the afternoon, the convenors would report on their assessment
of how the Work Plan should be amended in light of the morning session
and written responses to consultation. AEBC would particularly welcome
views on expectations of the Commission and how best to develop its
dialogue with the public.
4.
Copies of the slides summarising the working group convenors presentations
are reproduced at Annex A to these minutes. The following summarises
the comments made by participants in the open meeting:
Subgroup
A - Strategic decision-making
·
The Commission should consider how to relate science to public concerns
some of which might have a scientific justification but which might
also have a non-scientific basis
·
It would be important for AEBC to find out what people really thought
about the farm scale evaluations
·
AEBC should investigate concerns about damage to people's interests
and health, how agriculture would develop in future and the lack of
consultation about local developments. A number of people were pleased
to see that public perceptions had a place in the Work Plan
·
Joint fact finding with others was suggested as a possible working
method. The Commission was urged not to lose sight of the scientific
information already gathered by various groups
·
Notwithstanding their outcome, attention should be paid to the environmental
effects of the evaluations themselves
·
There had been a lack of meaningful consultation about the FSE proposals.
Notification periods for proposed trial sites had been too short
·
Horizontal gene transfer was the wrong term and should be replaced
with gene flow (horizontal gene transfer was nevertheless important
and should be included in the gene flow study). It was important that
gene flow work should not be delayed and, if possible, it should be
done in parallel with the work on the FSEs
·
The need for the Commission to address the question of the 'need'
for GM crops was raised
·
AEBC was reminded of its strategic role. It was suggested that it
should cover the benefits as well as the risks of biotechnology
·
It was pointed out that choice was important for growers as well as
consumers
·
Liability was an important issue as was the feeding of GM feedstuffs
to animals
·
A number of people suggested that AEBC was not yet as widely known
about as it should be
Subgroup B - Animal Modification
·
The scope of 'animals' should be broad enough to include, for example,
GM fish, lab mice and could cover changes in temperament of animals.
The AEBC study itself should also be broad, using for example citizens'
juries, to establish more precisely what people thought about issues
·
There were differing views about rights and wrongs of putting the
interests of sentient beings first. Some felt that the public could
see no reason for biotechnology/cloning to press ahead and that 'low
technology' agriculture should be the preferred option
·
The place of ethics in the debate was raised. It was felt that a proportionate
approach should be adopted. Intuition as well as strict ethical principals
should be taken into account
·
The opportunity for bodies to make more detailed submissions to AEBC
would be welcomed
·
It was felt by some that the animal welfare/protection expertise on
the subgroup should be strengthened
·
The subgroup should consider: future markets for GM animals; future
risks (perhaps using the history of BST as a lesson); substantial
equivalence; international work; and the lack of controls on imported
food or labelling of feedstuffs
Sub-Group
C - Horizon Scanning
·
AEBC was reminded of the importance of maintaining neutrality, especially
with regard to the framing of questions. The Commission should also
have a role in combating the secrecy of organisations
·
Genomics would be the next important phase of development
·
Crops for industry (eg chemical feedstocks and fuel) represented a
significant potential market for UK and an opportunity for AEBC to
get ahead of the game
·
It was pointed out that there was no effective European mechanism
for considering the ethical merits of the patent regime and AEBC was
asked whether it would have the capacity to consider patents
·
AEBC was advised to keep in view changing social trends - risk aversion
was currently a major trend in the UK but may not continue to be so
·
In order to get the right information AEBC would be well advised to
establish dialogues with the right people including senior R&D,
environmental scientists
·
The influence of the WTO on the global stage was highlighted
·
Assurance was sought that the AEBC would consider social and economic
trends alongside technological trends, and that it would not be assumed
that technological solutions were the only ones available.
Developmental Groups A (Consumer Choice and Public Attitudes to GM),
B (Bioremediation) and C (Legal Liability)
Presentations
(see Annex A) were made by convenors. Comments were not taken from
the floor.
Summing
up
5.
In summing up, the Chair thanked everyone for their relevant and concise
contributions. He also invited people to fill in the 2 forms provided,
the first to add any further points they wished to make and the second
to give an evaluation of the meeting.
Thursday 7 December - Formal Meeting
Introduction
and apologies for absence
1. Roger Turner had sent apologies. He was unwell.
Confirmation
of minutes of second meeting
2. Provisional minutes with suggested amendments highlighted in bold
had been circulated to Members. A further amendment had been suggested.
This and the other amendments were agreed.
Review
of morning discussion of Work Plan
3. The Chairman reminded all those present that the afternoon session
would be the first formal meeting of the Commission to take place
in public.
4.
The Chairman reported that the Commission had met informally on the
previous day. A brief account of that meeting would be included with
the minutes of the meeting and posted on the AEBC website. Two members,
Michael Banner and Ben Mepham had given a briefing session setting
out their approaches to ethical debate.
5.
Dr Mo Mowlam had joined the Commission for dinner that evening. She
was one of the Ministers the Commission reported to. In the course
of her remarks, she had emphasised how important it was to the Government
that the Commission should be, and should be seen to be, completely
independent.
6.
On behalf of the Commission, the Chairman thanked those who had made
comments at the public meeting, stressing how much Members had learned
from the session. They were enormously grateful for the time and effort
people had given. Having reflected, Members would consider what they
had heard and what they had read in the responses to the written consultation
as they discussed how to finalise the Work Plan. A further draft of
the Work Plan would be circulated to Members with the draft minutes
of the meeting.
ACTION: Secretariat
Commission
discussion and agreement on revised Work Plan
7.
The Chairman invited convenors to propose amendments to the Work Plan
in light of consultation and the public meeting, changes in or elaborations
on how the work would be taken forward and target dates for delivery.
Subgroup
A
8. The following amendments would be made:
·
The group recognised that the term 'horizontal gene transfer' was
too narrow a reflection of the proposed study and that 'gene flow'
(both horizontal and vertical) would be more accurate;
·
the whole of Annex 3 would be replaced with the objectives put forward
by the convenor during the public meeting (see Annex A).
ACTION: Justine Thornton
9.
The subgroup recognised the need to meet people in areas where farm
scale evaluations were being held and would consider the invitation
to visit the Highlands Council that had been extended during the morning's
discussions. They also proposed to take the opportunity of the Commission's
forthcoming meeting in Norwich to meet with local people and hear
their views.
10.
Members highlighted the need to: explore the relationship between
views on local goods and public goods (that something might be essential
for the well-being of society but "not in my back yard");
consider the international context; focus how to improve the process
rather than second-guess decisions made two years ago; and, ensure
that apparent gaps in public consultation should not be repeated in
future.
11.
The targets for producing outputs were discussed. There was a strong
feeling that it would be desirable to tackle gene flow immediately
and preferably in parallel with the farm-scale evaluations case study.
It was agreed that it was unlikely that resources would permit this.
However, it was also pointed out that the urgency of looking at gene
flow would be highlighted by the forthcoming growing season, which
would bring to the fore once again the debate surrounding separation
distances. AEBC was not established to deal with short-term crisis
management but Members agreed to inform themselves of the debate and
where possible assist in unblocking channels of communication. The
Deputy Chair suggested that it might be helpful if one or more of
the sub-group members could prepare a very short 'state of the debate'
paper to bring the Commission up to date with current controversies.
ACTION: Subgroup
[TOP]
Subgroup
B - Animal modification/Animals and biotechnology
12.
The Subgroup had held its first meeting earlier that week; the Commission
had now had an opportunity to discuss proposed work and to hear the
comments of those at the public meeting which had been enormously
helpful in offering views on the way forward.
13.
It was proposed that paragraph 10 of the Work Plan consultation paper
should be replaced with the primary question set out in the presentation
to the public meeting ie :
'How
well can current and likely future questions about biotechnology and
animals, including genetic modification, be addressed by the existing
regulatory and advisory machinery?
The broadening of the definition of biotechnology and the scope of
the term animals was noted, as were the strands of work proposed.
The title of the subgroup would change from "animal modification"
to "animals and biotechnology".
ACTION: Anna Bradley
14.
The Commission reflected on the priority to be given to ethics in
debates surrounding animals and biotechnology. A number of views were
expressed: some considered ethics had to have a place but could not
be pre-eminent, whereas others considered ethics (e.g. represented
by impacts on harm, risks, well-being, values) were fundamental. However,
it was agreed that while a formal ethical judgement was not necessarily
required, the Commission should at least lay out the ground. Issues
might be complex. For example, developments arising out of the human
genome project could give rise to increased numbers of animal experiments
amid increasing public anxieties about animal welfare. The dynamics
of these could present some difficult political problems and the AEBC's
job would be to draw out the social realities.
15.
The group would emphasise the need for high quality input on scientific
aspects of animal modification. This reflected a general principle
that the Commission should be prepared to evaluate scientific evidence
critically and the importance of ensuring that it was of the highest
quality. The group was also aware there could be a need to bring in
additional expertise in animal welfare and some areas of animal genetics.
16.
The group was conscious of the need to ensure that any consultation
with the public was meaningful and did not, for example, use unnecessarily
obscure scientific jargon. Essentially, the group would strive to
check its understanding of what it had learned from consultation.
17.
With regard to timetable targets, the subgroup would commission consumer
research/focus groups, which would take place in parallel with informal
discussions with experts during February. An issues paper would be
put to AEBC in April and a public consultation could be launched in
July. The aim would be to have some form of draft report in the Autumn.
ACTION: Subgroup
[TOP]
Subgroup
C - horizon scanning
18.
Paragraph 11 of the Work Plan would be replaced with the terms of
reference presented to the public meeting (see Annex A). The Subgroup
was pleased to have received and heard so many sources of additional
information. In light of this, they hoped to progress their work at
their next meeting on 22 January. Contributions to the database the
subgroup was developing would be very welcome.
ACTION: Julie Hill
19.
They needed to pay particular attention to setting up a sound mechanism
for scanning for further developments (e.g. via patents); getting
to grips with the broad international contexts in agriculture and
trade. Members wished to reassure industry that they would be looking
at potential benefits as well as risks to UK economy in the course
of the subgroup's work.
20.
Commercial confidentiality could be a problem but it was noted that
this was only the case where the research had moved into development
phase. For the longer horizon, information could be found from, for
example, the work of scientific institutes and published papers
ACTION: Subgroup
21.
There was discussion about the remit and the need to define the scope
of biotechnology for the purposes of the subgroup. For example, it
should encompass non-food crops which create opportunities but also
pose environmental questions. However, a very wide definition would
have implications on workload and delivery.
22.
With regard to timetable targets, the subgroup would submit a report
to AEBC in September. It would decide in January when to take evidence.
Developmental Group A - Consumer Choice and Public Attitudes
23.
The convenor would review the paragraph in the Work Plan and send
a revised draft to the secretariat.
ACTION: Robin Grove-White
24.
The subgroup had yet to meet but would do so before AEBC's February
meeting in Norwich.
25.
The group would aim to create a resource for the Commission as a whole,
which would involve creating and maintaining a network. The basis
of this would, it was hoped, emerge from an academic workshop planned
for January. The aim of the workshop was to bring together - possibly
for the first time - people from a variety of disciplines, using different
methodologies and approaches. In view of the somewhat experimental
nature of this approach, the number of 'observers' including those
from AEBC would be limited. Some of the developmental group members
would, however, be present and the Commission would be kept fully
informed. The convenor would start this process off by circulating
a list of those attending the workshop. A written report of the workshop
would be prepared for the February meeting of the Commission.
ACTION: Robin Grove-White
Developmental
Group B - Bioremediation
26.
The paragraph in the Work Plan would be amended to reflect the presentation
given at the public meeting (see Annex A).
ACTION: Rosie Hails
27.
The Commission was concerned to adopt a balanced approach, considering
both potential risks and benefits of all aspects of biotechnology
including the enhancement of indigenous bacterial communities for
bioremediation.
28.
The sub-group might benefit from the contribution of non-scientists.
Developmental
Group C - Liability
29.
The convenor would redraft the relevant paragraph in the Work Plan
to cover the questions that need addressing and monitoring of laws.
Derek Langslow would transfer to the liability subgroup from the one
on consumer choice and public attitudes.
ACTION: Justine Thornton
Further topics for study
30.
As a general point, it was agreed that AEBC would incorporate a note
of other topics suggested for study in order to keep them in view
as the Work Plan progressed.
ACTION: Secretariat
Dates
for future meetings
31.
The dates in paper AEBC/00/19 were agreed. Some interaction with those
at the Roslin Institute would be useful when in Edinburgh. The public
session of that meeting could involve an evening meeting and be somewhat
more interactive in nature.
32.
The Secretariat would work up the paper to include subgroup meeting
dates, venues and other events (e.g. publication of the Work Plan).
ACTION:
Secretariat
AOB
33.
The Commission returned to the subject of the place of closed sessions
within its open meeting structure and agreed the following:
·
the commitment to openness and transparency should underpin all its
work;
·
meetings should be held regularly but not exclusively in public;
·
it would be open about the format for each meeting and the reasons
why it had been chosen;
·
it should not be defensive about meeting in private when this was
the best way of making progress.
34. Members also discussed mechanisms for ensuring that the Commission
as a whole could be kept up to date on the work of the sub-groups.
The following solutions were proposed:
minutes
of subgroup meetings should be circulated to all Members as well as
being posted on the website;
members
should be allowed to attend meetings of any subgroups;
there
should be regular discussions between sub-group convenors;
meetings
of whole Commission should have time allocated to workshops at which
other members could be briefed by and have an opportunity to discuss
substantive issues coming through from subgroups.
35.
It was agreed that subgroups could issue their own consultation letters.
However, final drafts and lists of proposed consultees should be circulated
to all Commission members so that they had an opportunity to comment
(a five day deadline would be the norm). It would also be made clear
that, in these cases, consultations were being made by the sub-group
and not the whole Commission.
36. The secretariat was asked to draft a protocol for subgroup communications
taking on board these points.
ACTION: Secretariat
Annex
A
Copies
of the slides used by sub-group convenors for the presentations made
at AEBC public meeting on 7 December
Sub-Group
A - Decision-making in Biotechnology
1.
Members of the Group:
Dave Carmichael, Phil Dale, Robin Grove-White, Rosie Hails, Jeff Maxwell,
Sue Mayer and Justine Thornton (Convenor)
2.
The Group's Remit:
To consider, and report on, decision-making by the Government in the
area of biotechnology.
We
have chosen to do this through two case studies:
· farm scale trials
· gene-flow
3.
Why are we looking at the Farm Scale Trials?
· The trials have become extremely contentious despite aiming
to resolve controversy
·
The commercial growing of the GMHT crops in the trials depends upon
the outcome of the trials and Ministers are likely to face difficult
decisions when the results are published
4.
The role of the AEBC is to provide strategic advice to the Government.
By choosing a case study in an important and difficult area, we hope
to fulfil this role and to give advice that may assist in future decision-making.
5.
To evaluate the role of FSE's in the regulatory process and in appraising
the impact of GM plant technology on the environment. This objective
will be appraised by:
·
reviewing the reasons for setting up the trials;
· reviewing the extent of governmental, commercial and public
consultation and decision-making processes used in agreeing the objectives
and the implementation of the trials;
· understanding the agreed objectives of the trials, and the
protocols used to carry them out;
· reviewing the parameters and extent of the data available
to reach conclusions;
· reviewing the public's opinions and perceptions of the FSE's;
6.
Identifying the significant gaps in information that may remain following
the conclusion of the FSE's relevant to appraising the impact of GM
plant technology on the environment taking into account the public's
continuing concerns about the application of GM plant technology.
7.
Working Methods
· Objectives: We established the objectives of our report (after
extensive debate)
· Background Papers: We have requested a series of 'background
papers' to assist the group in understanding the details of the debate.
We will use these to decide on the scope, content and direction of
the final report
· Considering responses to our consultation on the work plan
and any other comments (ongoing)
· Evidence taking session
· Compiling the report
8.
Our discussions are ongoing. However
· There are different views as to why the farm scale trials
were set up. Our report will examine the reasons for setting up the
trials and for any confusion (if any) as to the reasons for the trials;
· The trials appear to raise three main issues:
· the merits of the scientific experiment
· public concern about the trials
· the role and relationships of the regulatory bodies taking
decisions about the trials and GMHT crops
· We have requested background papers on each of these
· aspects
9.
As regards public concern, we have identified three different aspects:
· what the public thought the FSE's were going to tell them
· what the FSE's will actually tell them
· what they believe future FSE's should be telling them
Sub-Group B - Animal Modification
1.
Members of the Group:
Michael Banner, Anna Bradley (Convenor), Helen Browning, Matthew Freeman,
Judith Hann, Jeff Maxwell and Ben Mepham
2.
The Primary Question
· Can (will) current and likely future questions about biotechnology
and farm animals, including genetic modification, be addressed by
the existing regulatory and advisory machinery?
3. How to Address the Question
1. Identify and scope the current and likely future issues about animals
and biotechnology
2.
Describe existing regulatory and advisory machinery and the way each
part currently interprets its brief
3.
Map 1 onto 2 and identify gaps and possible solutions
4.
Recognise:
· Dangers of duplication/important issues falling between two
stools
· May need to involve/co-opt additional expertise in animal
genetics
5. Process and Timetable - Phase One
Step
1
Meeting of sub group to agree brief for citizen focus groups and letter
to experts describing work planned and inviting input
Step
2
i) Focus group work to help understand public/citizens' concerns
ii) Sub committee meeting for briefing from a small number of experts
Step
3
Sub-committee meeting to compile issues consultation paper based on
i) and ii)
above
l
Discussion with Commission of issues consultation paper
l Circulation to experts and others for comment and public commission
session
6.
Process and Timetable - Phase Two
Step
4
Sub-committee paper on regulatory structures and meeting with experts
on regulatory and advisory structures
Step
5
Sub-group meeting to map issues onto structures and draft recommendations
Step
6
Draft report to Commission
Step
7
Report out for consultation and discussion at commission public session.
Step
8
Final report for Commission discussion and agreement with plan for
promoting and following through recommendations
Sub-Group
C - Horizon Scanning
1.
Members
Ed Dart, John Gilliland, Julie Hill (Convenor), Edith Iweajunwa, Derek
Langslow, Roger Turner
2.
Terms of Reference
· To keep the AEBC well informed about current and future national
and international developments that are relevant to fulfilling its
strategic remit.
3.
This will include information on:
· Trends in biotechnologies, in agricultural practice and policy,
and in environmental issues;
· Trends in other technologies, where these may interact with
biotechnologies;
· Relevant social, economic, legal and political trends i.e.
those that will have a bearing on how biotechnology is shaped and
how it is received by society.
· The work of the sub-group will take into account the work
of other bodies with a horizon-scanning role.
· The sub group will make regular reports to the full AEBC.
· Examples of other bodies undertaking Horizon-scanning
· Human Genetics Commission (HGC)
· Animal Procedures Committee (APC)
· Advisory Committee on Agriculture and Environment (ACRE)
· Foresight Initiative
· Economic and Social Research Council (ESRC)
· Environment Agency
4.
Issues
· Confidentiality of Information
· Predicting timescales
· Appraising the full range of implications of a development
or trend
· Deciding relative impacts
· Pinpointing responsibilities
Developmental
Group A - Consumer Choice and Public Attitudes to GM
1.
Members of the Group:
Robin
Grove-White (Convenor), Helen Browning, Dave Carmichael, Ed Dart,
Sue Mayer, Ben Mepham and Derek Langslow
2.
Nature and range of public responses
· Insight from social research
· Relationships to regulatory framework
· Implications for future regulations
· Implications for future R & D
Developmental Group B - Bioremediation
1.
Members of the Group:
Rosie Hails (Convenor), Phil Dale and Judith Hann
2.
Risk Issues
· Toxicity of intermediates
· Imperfect clean up
· Regulation of application of inocula
· Gene flow
· Failure to detect contaminants
3.
Why should the AEBC be involved?
· To maximise the opportunities for the environment
· To ensure the safe development of this technology
· To ensure adequate regulation of novel methods including
GM
· To provide strategic advice for development, regulation and
risk assessment
4.
Next Steps?
· Produce a paper summarising the current position in the UK
· Seek expert advice on potential risks to the environment
· Increase public awareness of the issues, policies and responses
· Horizon scan to anticipate future needs, products and potential
risks
· Provide government with independent strategic advice on the
implications of bioremediation for the environment
Development Group C - Legal Liability
1.
Members of the Group
Matthew Freeman, John Gilliland and Justine Thornton (Convenor)
2. The Group's Remit
· To consider the existing laws on liability for damage caused
by GMO's and to propose to the AEBC a work plan for a report on liability
3.
Why is liability so important?
· We need to be clear who is to pay if GM crops cause damage
· In the US, farmers may be sued over the GM corn found in
taco shells
· Europe has turned its attention to liability for environmental
damage and GMO's
· "Liability is already of immediate significance and
is expected to become even more so in the future" (NFU - response
to AEBC work plan)
· Liability "should be an immediate priority" (FoE
- response to AEBC work plan)
4. Questions that need to be addressed:
· What constitutes damage to the environment?
· Who should be liable for damage to the environment:
bio-tech companies/taxpayers/farmers?
· Should liability depend on fault or follow automatically
from using GMOs?
· Should there be a compensation fund in case the responsible
person cannot be found?
· Should there be a compulsory insurance scheme?
· Should GMO's be regulated separately from other "dangerous
activities"?
The
debate needs to extend beyond the lawyers.
Title
Surname First name Institution
Mr Agnew Stuart NFU
Mr Alston David The Highland Council
Mr Anderson Tina
Ms Appleton Josie Spiked
Dr Bale Mark Human Genetics Commission
Ms Barber Karen Food & Drink Federation
Ms Bates Angela Castle Blytham PC, GM Working Group
Ms Baynton Clair FSA
Dr Bennett David European Federation Biotech Task Group
Mr Bruce Donald Church of Scotland
Ms Chavda Rashmi DTI
Ms Clarke Caroline The Burnhams Group
Ms Cooke Sally Dorset Agenda 21
Ms Croft Tanya Citigate Westminster
Ms Cutler Kate Citigate Westminster
Ms Davies Barbara RDS
Ms Devereux Claire Five Year Freeze Campaign
Ms Dibb Sue National Consumer Council
Dr Duncombe Tracey
Ms Durning Jo DTI - OST
Ms Foster Ann Monsanto UK Ltd
Mrs Foster Claire C of E Board for Social Responsibility
Mr Foulk Ray GMO Campaign
Mr Freear Matt COI
Mrs Fry Elizabeth
Dr Garcia-Alons Monica
Mr Garrod Michael World Association of Beet and Cane growers
Ms Godfrey Janet
Ms Guldberg Helene
Mrs Hamblin Yvonne Castle Blytham PC, GM Working Group GroupM Working
Group
Ms Harding Diana Hemel Hempstead GM Action Group
Ms Herbert-Step Joanna
Ms Herczeg Valerie TJB Publications (Agrow)
Dr Hinton Jackie Centre for Ecology & Hydrology
Ms Hughes Jessica Smithkline Beecham
Dr Johnson Brian English Nature
Mr Kirst R Hemel Hempstead GM Action Group
Ms Lansdell Suzannah The Environment Council
Mr Leggett Ken
Mr Levidow Les Open University
Miss Lindsey Nicola Imperial College, London
Ms Lueginger Julie
Mrs MacDonald Rose Farming & Livestock Concern UK
Mrs MacArthur-Clarke Judy Farm Animal Welfare Council
Lord Melchett Peter Greenpeace UK
Mr Montgomery Archie National Farmers Union
Dr Morrod Rod British Crop Protection Council
Mrs Mukerji R
Dr Padilla Ana Parliamentary Office of Science & Technology
Ms Patel Mona Consumers Association
Mrs Patisson E
Mr Patisson P H
Mrs Percival Karen Nestle UK Ltd
Dr Pidgeon John Institute of Arable Crops Research
Dr Potter Martin RSPCA
Ms Price Becky GeneWatch
Mrs Priest Lynn CROW
Mr Rainbird Clive Aventis Crop Science
Mr Reed Michael AEEU
Dr Robinson Vicky RSPCA
Ms Ryan Angela Institute of Science in Society
Mr Sandbach Peter Novartis UK Ltd
Shorter R Christian Ecology Link
Dr Steinbrecher Ricarda Econexus
Mr Thomas Jim Greenpeace UK
Tomson Andrew Highlands & Islands GM Concern
Mr Turner John Castle Blytham PC, GM Working Group
Dr Turner Jacky Compassion in World Farming
Dr Wakeham D Andrew DETR
Mrs Wallace Elizabeth
Mr Walton Declan Arkleton Trust
Mr Woiwood Ian Entomology & Nematology Dept
Mr Wyld Barney Citigate Westminster
|